AbbVie surprised Wall Street today with a third-quarter performance that turned out much better than expected and a new 2014 forecast that also extends well beyond what analysts predict.
The Lubrizol Corporation has announced an alliance between Lubrizol LifeSciences, a supplier of...
Mylan has reported earnings of $499.1 million in its third quarter. On a per-share basis, the...
Daiichi Sankyo announced that the FDA's Cardiovascular and Renal Drugs Advisory Committee voted...
Dust has always been an unwanted byproduct of tablet manufacturing. In a perfect world, all powder would flawlessly flow into the hopper, and 100% of the product would emerge as finished tablets. In practice, though, most tablet presses are so inundated with dust after an eight-hour run that they form miniature snow piles on both sides of the feeder, and build-ups of material occur around the takeoff bar and recirculation channel.
A $500M lawsuit against Kimberly-Clark alleges the company falsely claimed its surgical gowns protected against Ebola and other infectious diseases. The suit alleges that the company knew for at least a year that its Microcool Breathable High Performance Surgical Gown had failed industry tests of impermeability to blood and microbes.
Brochure details the company's comprehensive range of recording and controlling instrumentation for a broad range of industries. Under the brand names ScreenMaster, ControlMaster and Commander, the products include process controllers, digital indicators, chart and strip recorders and paperless videographic recorders.
Biosimilars have increasingly become an important and somewhat controversial topic in the healthcare space. Depending on who one speaks to, the opinion on biosimilars changes. However, there are certain truths that all stakeholders should keep in mind.
SAFC, a global supplier of a a wide range of services to the biopharm and pharmaceutical industry, has recently expanded their Madison, Wisconsin facilities to neighboring Verona to rev up their high-potency API manufacturing capabilities.
Exponent™ 2 features a combination of ClearFoil® and a coextruded non-crystalline polyester sealant. The material targets pharmaceutical and other chemically-sensitive applications which require exceptional barrier and clarity.
CNN's Anderson Cooper investigates a new study comparing the effects of drinking soda to smoking.
Dialysis patients need to choose their heart medicine carefully, as Canadian researchers say that some beta blockers are easily removed from the blood during treatment. Also, people who eat a Mediterranean diet may decrease their risk of developing kidney problems.
Call it drugs for the departed: Medicare's prescription program kept paying for costly medications even after patients were dead. The problem was traced back to a head-scratching bureaucratic rule that's now getting a second look.
Impax Laboratories has announced a reorganization of its research and development (R&D) organizations and a prioritization of the project portfolios within the generic and brand businesses
Sanitary Belt Conveyor is designed for bulk tablets, capsules, softgels, and powders as well as ingredients on regulated and OTC pharmaceutical and nutritional supplement manufacturing and packaging lines.
Fever? Headache? Muscle aches? Forget about Ebola — chances are astronomically higher that you have the flu or some other common bug. That message still hasn't reached many Americans, judging from stories ER doctors and nurses swapped this week at a Chicago medical conference.
Federal regulators announced Thursday they were suing Gerber, the well-known baby food maker, for claiming that its Good Start Gentle formula can prevent or reduce allergies in children.
Bristol-Myers Squibb and Lonza have announced a multi-year expansion of their existing biologics manufacturing agreement. The contract expansion will include the production of commercial quantities of a second Bristol-Myers Squibb biologic medicine at Lonza’s mammalian manufacturing facility in Portsmouth, NH.
Virginia's Gov. Terry McAuliffe said Thursday that UniTao Pharmaceuticals LLC has purchased the Boehringer Ingelheim plant that's slated to close by the end of the year.